Nah. Have to disagree with you here. They have been
Nah. Have to disagree with you here. They have been together in some form or another for years - pre Nanoviricide - which immediately contracted with Kard. NNVC bought property from Theracorp Pharma in 2005 - K.Menon was on Theracour board and Theracour contracted with Kard. Anil Duwan was president and director of Theracour at the time and became president and director of NNVC also - holding both positions - both companies contracting Kard and Menon on board of Theracour and employed by NNVC, Ehlrich was Theracour CFO and then NNVC CFO and now major NNVC stockholder. NNVC was a share machine for the longest time, as many people here who were burned know. The activity circle revolves around Kard - the only nonpublic company involved here. And fwiw - Menon's son is listed as Kard founder in Nanoantibiotics 10k (please go to Edgar and read it from the source) - even though he was still a college student when company started. from the nanoabt registration statement p 31: "Mr. Rajah Menon. Mr. Menon has served as the Company’s President and as a Director since the Company’s inception on April 10, 2013. Mr. Menon attended Amherst College from 1996 -2000 where he received his Bachelor of Arts’ degrees in Economics and Law Jurisprudence and Social Thought. After graduation in 2002, and to 2004, Mr. Menon worked as an analyst for Loan Pricing Corporation, a subsidiary of Reuters. In 2002, Mr. Menon founded Kard Scientific, a preclinical contract research organization providing life science services to companie based near Boston, MA, and today he remains its principal shareholder. In the years 2004-2008, Mr. Menon was employed at Blackrock Financial Management as a Vice President within the Portfolio Analytics Group. >From 2008 – 2013, Mr. Menon was employed at Markit as a Product Manager within its Structured Finance group."
Blah. Too many circles. Red flags. As investors, we are wise to look at such things without emotion. Without labels of 'basher' if one finds something of concern in a company. I will no longer be heavy in this company. Once had lopsided position. No more. But I will continue to hold shares for Kevetrin - which is the real thing. Even if Kevetrin is not outstanding on its own - if it lacks toxicity and is well-tolerated, it has the potential to become a much used piggyback drug. Kevetrin is the positive story of this company. Leo creating so many legal business deductions for the same crowd is a reason to be cautious and not go overweight.
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Holiday Heatwave Meets Winter Cheer with Martin's Rolls Hold onto your oven mitts, folks, because Martin’s Famous Potato Rolls and Bread is stirring up the winter doldrums with an unexpected twist this holiday season. Forget the old cranberry sauce routine—it’s all about mixing sunny vibes with frosty festivities in their "Very Merry Martin’s: Holiday Heatwave."...
Continue Reading
Who would've thought your morning coffee ritual could be in cahoots with a silent tooth villain? Well, Dr. Kari Sakurai at Pacific View Smile Center slices through the noise with some fascinating insights on early tooth decay, spun out in an article by HelloNation. You see, Dr. Sakurai, like a dental James Bond, is fighting the good fight against cavities before they even...
Continue Reading
Tackling the Age-Old Heating Puzzle Ah, the charm of an older home—from the creaky floors to the vintage architecture, it's something else. But, let's face it, keeping these houses warm can feel like patching up an old ship. Our man Reid Sittler, HVAC aficionado from Massillon, Ohio, shares some no-nonsense insights on how to stop your precious heat from slipping...
Continue Reading
Digging Deeper into Check Point's Latest Figures When Check Point Software Technologies Ltd. (NASDAQ:CHKP) throws numbers at the wall, not everything sticks, but there's always something telling. The Q3 financial results for 2026 are out, and it's a mixed bag—coffee’s getting cold before you parse through it. Revenue and Subscription Dynamics Let's cut to it: total...
Continue Reading
Strengthening the Backbone of Virginia's Power Supply Ever had your lights flicker on a windy day and wondered if the power grid would hold? Potomac Edison, under the banner of FirstEnergy Corp., is stepping up with a game plan to fortify the electric spine of Virginia and its neighbors. They're diving into a multi-state adventure, rebuilding and erecting 138 kV...
Continue Reading
Enterprises on AI: From Dreams to Doing Alright, here’s a nugget for you: AI isn't just pie-in-the-sky jazz anymore. Some folks are finally bringing it down to Earth. Emergys, a player in digital transformation, is shaking hands with Glean, renowned for their enterprise AI chops, to turn enterprise chaos into clarity. It's all about squeezing out real returns and...
Continue Reading
Another Quarter Under the Belt Just when you think the hospitality industry's running out of steam, Choice Hotels International decides to shake things up. Reporting their third quarter 2026 results, the big picture here demands an attentive eye from investors. In the turbulent world of lodging franchises, NYSE:CHH is making waves, and I mean literal waves, as they surf...
Continue Reading
A Deep Dive into the Prayers of Apostle Paul Gary P. Rohrmayer's latest devotional takes believers on a unique journey, exploring the Apostle Paul's prayers across his missionary paths. But don't expect just another preacher prophesying from the pulpit. This is more like peeling back layers of history, bit by bit. 28 Days of Spiritual Insights Each day within the book...
Continue Reading
Disruptive Cooling Technology in AI's Fast Lane The data centers that underpin our computational age are becoming sweatshops with all this AI-driven heat. Enter Chemours and its fresh Faizeon™ cooling fluid line, ready to be the unsung hero tackling the ever-mounting thermal loads from burgeoning AI and high-performance computing (HPC). These babies are designed to deal...
Continue Reading
News in the medical world isn't just rattling desks today; it's a purposeful signal for cancer care's transformation. Florida Cancer Specialists & Research Institute (FCS) has beefed up its team, embracing Carlos Barbur, DO, an oncologist who's not just skilled but steeped in disciplines crucial for the health of many. Think of this as another puzzle piece fitting snugly...
Continue Reading
Top 5 Most Recently Viewed Articles
The Expanding Cannabis Market: Insights and Growth Trends The cannabis market is on a remarkable trajectory, estimated to grow from USD 72.83 billion in 2025 to an impressive USD 125.76 billion by the year 2030. This growth signifies a compound annual growth rate (CAGR) of 11.5%, driven by various factors including increasing legalization, a surge in therapeutic demand,...
Continue Reading
Cycurion Expands Market Reach with New Contracts Worth $1 Million MCLEAN, Va. — Cycurion (NASDAQ: CYCU), a prominent name in cybersecurity solutions, has marked a significant milestone by announcing five new contracts valued at around $1 million. These agreements, finalized in September, are poised to enhance the company’s growth trajectory, generating approximately...
Continue Reading
Unexpected Scene on Wall Street It's not your regular morning in New York when the city preps for a parade that's been five decades in the making. The New York Knicks, finally snapping their 53-year NBA title drought, are heading down the iconic Canyon of Heroes. For some, this might just be a sports milestone, but make no mistake, it's got a way of energizing the whole...
Continue Reading
SP Group Announces Closure of Accoat Production Facility SP Group, owning Accoat A/S as a subsidiary, has decided to terminate all production operations at its Kvistgaard facility within the next year. This strategic move is meant to align with the evolving objectives of the entire SP Group. Assessing the Impact of Production Phase-Out The winding down process is...
Continue Reading
Elon Musk and the Future of Internet Access Telecom giants have long dominated the landscape of internet access, but a significant shift is now in progress. Renowned author and entrepreneur James Altucher has recently highlighted Elon Musk's Starlink as a revolutionary solution for internet connectivity. Altucher asserts that Starlink, with its network of satellites,...
Continue Reading
